foxo4-dri peptide senolytic 2023 2024

foxo4-dri peptide senolytic 2023 2024 inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI: Human Trial Status, Cancer

Name: foxo4-dri peptide senolytic 2023 2024 inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI: Human Trial Status, Cancer
Brand: www.rasophiles.fr
SKU: 38931046261
Price: 25.86 USD
Availability: InStock
Rating: 4.639 (7 reviews)

SKU: 38931046261

4.6

USD25.86 USD71.86

Pay in 4 interest-free payments of $6.46 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 25 - Aug 30

Description

Structurally derived from a class of small-molecule inhibitors, 5-Amino-1MQ is widely recognised for belonging to a new generation of chemically engineered compounds designed to influence specific biochemical processes at the cellular signalling level

No LD50 reached in preclinical studies

This peptide is still experimental, and its risk profile is less characterized

Children with these conditions often exhibit sudden-onset obsessive compulsive disorder (OCD), tics, rage episodes, and severe separation anxiety following a strep or other infectious trigger